Class IIIReported 2025-10-29

Cetirizine Hydrochloride Tablets USP 10 mg, 500 Tablets bottles, Manufactured by: Unique Pharmaceuticals Labs, (A Div. of J.B. Chemicals & Pharmaceuticals, Ltd.), Mumbai 400 030, India. Distributed by: Rising Pharma Holdings, Inc., East Brunswick, NJ 08816, NDC 16571-402-50

Recalled by JB Chemicals and Pharmaceuticals Ltd

Reason for Recall

Tablet/Capsules Imprinted with Wrong ID

Recall Number

D-0033-2026

Classification

Class III

Status

Ongoing

Category

drug

Initiated

2025-09-12

Reported

2025-10-29

Distribution

U.S. Nationwide

Code Info

Lot # PY925014, PY925013, Exp. 1/31/2028

Source: openFDA enforcement report. WhichRecall is not affiliated with the FDA. See our disclaimer.